Search results for "Crania"

showing 10 items of 885 documents

The aristaless (Arx) gene: one gene for many "interneuronopathies".

2009

The ARX (Aristaless-related (X-linked) homeobox) gene is not only present in arthropods and their ancestors, but also in vertebrates including humans (ARX orthologs). The gene is composed of 5 coding exons and it is expressed predominantly in foetal and adult brain and skeletal muscle. In this review we report on our experience and review the existing literature on the genotype and phenotype heterogeneity associated with ARX abnormalities in humans ranging from severe neuronal migration defects (e.g., lissencephaly), to mild forms of X-linked mental retardation without apparent brain abnormalities. The ARX-related disorders are reviewed focusing on their clinical features and on the role of…

Doublecortin ProteinGenotypeLissencephalyBiologyNeuronal migration defectsGeneral Biochemistry Genetics and Molecular BiologyExonMiceGenotype-phenotype distinctionSettore MED/38 - Pediatria Generale E SpecialisticaInterneuronsmedicineAnimalsHumansAbnormalities MultipleGeneZebrafishGeneticsHomeodomain ProteinsGeneral Immunology and MicrobiologyARX homeoboxmedicine.diseasePhenotypeCranial Nerve DiseasesPhenotypeMultigene FamilyMental Retardation X-LinkedHomeoboxAbnormalityTranscription FactorsFrontiers in bioscience (Elite edition)
researchProduct

Ketamine in acute phase of severe traumatic brain injury “an old drug for new uses?”

2021

AbstractMaintaining an adequate level of sedation and analgesia plays a key role in the management of traumatic brain injury (TBI). To date, it is unclear which drug or combination of drugs is most effective in achieving these goals. Ketamine is an agent with attractive pharmacological and pharmacokinetics characteristics. Current evidence shows that ketamine does not increase and may instead decrease intracranial pressure, and its safety profile makes it a reliable tool in the prehospital environment. In this point of view, we discuss different aspects of the use of ketamine in the acute phase of TBI, with its potential benefits and pitfalls.

DrugSecondary insultmedicine.medical_specialtyTime FactorsIntracranial PressureTraumatic brain injurySedationmedia_common.quotation_subjectCritical Care and Intensive Care MedicineNeuroprotectionCooperative sedation03 medical and health sciencesViewpointTraumatic brain injury0302 clinical medicinePharmacokineticsBrain Injuries TraumaticmedicineHumansHypnotics and SedativesKetamineIntensive care medicineIntracranial pressuremedia_commonAnesthetics DissociativeAgitationbusiness.industrylcsh:Medical emergencies. Critical care. Intensive care. First aid030208 emergency & critical care medicinelcsh:RC86-88.9medicine.diseaseNeuroprotectionSafety profileSedationKetaminemedicine.symptombusiness030217 neurology & neurosurgerymedicine.drugCritical Care
researchProduct

Prophylaxis of hemicrania continua: two new cases effectively treated with topiramate.

2007

Hemicrania continua (HC) is an uncommon and under-recognized primary headache disorder characterized by a strictly unilateral continuous headache of moderate intensity with possible exacerbations and associated with ipsilateral autonomic features. HC has generally a prompt and enduring response to indomethacin although 25% to 50% of treated patients develop gastrointestinal side effects. These cases pose a difficult management challenge as no other drug is consistently effective in HC. Recently 2 HC patients responsive to topiramate treatment have been reported. Here we describe 2 more patients effectively treated with topiramate. Neither reported any side effects and one had persisting res…

DrugTopiramateAdultmedia_common.quotation_subjectmedicine.medical_treatmentIndomethacinNeurological disorderFructoseCentral nervous system diseaseDrug withdrawalPrimary headacheTopiramateProfilaxismedicineHumansmedia_commonbusiness.industryAnti-Inflammatory Agents Non-SteroidalHeadacheHemicrania continuaMiddle Agedmedicine.diseaseAnticonvulsantNeurologyHemicrania continuaAnesthesiaGastritisRetreatmentSettore MED/26 - NeurologiaAnticonvulsantsFemaleNeurology (clinical)businessmedicine.drugHeadache
researchProduct

Specific modulation of corticospinal and spinal excitabilities during maximal voluntary isometric, shortening and lengthening contractions in synergi…

2011

Non-technical summary  The neural control of muscle activity differs during voluntary shortening and lengthening contractions. In this paper, we show that the relative contribution of both cortical and spinal mechanisms to the modulation of neural activation is specific during lengthening contraction and differs between synergist muscles. Knowledge of spinal and corticospinal excitabilities modulations during shortening and lengthening muscle contraction improves our understanding of the processes that underlies the neural control of muscles during dynamic contractions.

Dynamic contractionsPhysiologybusiness.industrymedicine.medical_treatmentLengthening contractionIsometric exerciseAnatomyTranscranial magnetic stimulationNeural controlMedicineSilent periodMuscle activityH-reflexbusinessNeuroscienceThe Journal of Physiology
researchProduct

Cerebellar magnetic stimulation decreases levodopa-induced dyskinesias in Parkinson disease

2009

BACKGROUND: The neural mechanisms and the circuitry involved in levodopa-induced dyskinesia (LID) are still partially obscure. LID can be considered the consequence of an abnormal pattern or code of activity that originates and is conveyed from the basal ganglia to the thalamus and the cortical motor areas. However, not only striatothalamocortical motor circuits but also other interconnected pathways could be implicated in its pathogenesis. METHODS: In a series of experiments, we applied repetitive transcranial magnetic stimulation (rTMS) over the lateral cerebellum in a group of patients with advanced Parkinson disease, to investigate whether modulation of cerebellothalamocortical circuits…

Dyskinesia Drug-InducedLevodopaCerebellummedicine.medical_treatmentCTBStmSeverity of Illness IndexrehabilitationNOLevodopaNeural PathwaySeverity of Illness Index; Analysis of Variance; Levodopa; Dyskinesia Drug-Induced; Humans; Cerebellum; Aged; Neural Inhibition; Thalamus; Motor Cortex; Parkinson Disease; Evoked Potentials Motor; Neural Pathways; Middle Aged; Neuronal Plasticity; Transcranial Magnetic StimulationThalamusCerebellumNeural PathwaysBasal gangliamedicineHumansEvoked PotentialsThalamuAgedAnalysis of VarianceNeuronal PlasticityDyskinesiaMotor CortexNeural InhibitionParkinson DiseaseMiddle AgedEvoked Potentials MotorTranscranial Magnetic StimulationAged; Analysis of Variance; Cerebellum; Drug-Induced Dyskinesia; Evoked Potentials; Motor; Humans; Levodopa; Middle Aged; Motor Cortex; Neural Inhibition; Neural Pathways; Neuronal Plasticity; Parkinson Disease; Severity of Illness Index; Thalamus; Transcranial Magnetic StimulationTranscranial magnetic stimulationmedicine.anatomical_structureMotorDyskinesiaDrug-Inducedparkinson's diseaseSettore MED/26 - NeurologiaDrug-Induced DyskinesiaNeurology (clinical)Primary motor cortexmedicine.symptomPsychologyNeuroscienceHumanMotor cortexmedicine.drugNeurology
researchProduct

Which direction should I go? A quest for understanding the effect of TMS stimulus orientation on evoked responses

2023

The orientation of the electric field (E-field) induced by transcranial magnetic stimulation (TMS) plays a significant role in determining the magnitude of motor evoked potentials (MEP) and TMS-evoked potentials (TEP). However, fundamental mechanisms explaining the interaction of the induced E-field and the underlying neuronal populations are still largely unknown. We recently entered a quest to understand and describe neurophysiological and physical factors affecting the effect of the E-field orientation on the MEP and TEP. We developed a dual-coil TMS transducer capable of fast and accurate electronic control of the induced E-field orientation. With this transducer, we could scan the effe…

EMGelektromyografiahermo-lihastoimintaTMSGeneral Neurosciencetranscranial magnetic stimulationtranskraniaalinen magneettistimulaatioBiophysicsEEGNeurology (clinical)orientationmotoriikkaBrain Stimulation
researchProduct

Lymphatic vessels are present in human saccular intracranial aneurysms

2022

AbstractSaccular intracranial aneurysm (sIA) rupture leads to subarachnoid haemorrhage and is preceded by chronic inflammation and atherosclerotic changes of the sIA wall. Increased lymphangiogenesis has been detected in atherosclerotic extracranial arteries and in abdominal aortic aneurysms, but the presence of lymphatic vessels in sIAs has remained unexplored. Here we studied the presence of lymphatic vessels in 36 intraoperatively resected sIAs (16 unruptured and 20 ruptured), using immunohistochemical and immunofluorescence stainings for lymphatic endothelial cell (LEC) markers. Of these LEC-markers, both extracellular and intracellular LYVE-1-, podoplanin-, VEGFR-3-, and Prox1-positive…

EXPRESSIONPROX1biomarkkeritAneurysm RupturedPathology and Forensic Medicinelymphatic vesselsCellular and Molecular NeuroscienceimusuonistoHumansLymphangiogenesisCerebral aneurysmkallonsisäinen aneurysmaARTERYInflammationtulehdusaneurysma3112 NeurosciencesIntracranial AneurysmThrombosisWALLVascular Endothelial Growth Factor Receptor-3aivoverenvuotolymphangiogenesissaccular intracranial aneurysmcerebral aneurysmLymphatic vesselsinflammationADVENTITIAL LYMPHATICSMAST-CELLSNeurology (clinical)BiomarkersSaccular intracranial aneurysmActa Neuropathologica Communications
researchProduct

Fossil remains of Macaca sylvanus florentina (Cocchi, 1872) (Primates, Cercopithecidae) from the Early Pleistocene of Quibas (Murcia, Spain)

2011

The macaque material from the Early Pleistocene site of Quibas (Albanilla, Murcia, Spain), including dentognathic remains, isolated teeth and some postcranial bone fragments, is described. Both metrically and morphologically, this sample must be attributed to Macaca sylvanus (the Barbary macaque). This species is currently distributed through North Africa and Gibraltar, but was much more widely distributed during the Plio-Pleistocene, being represented by several European fossil subspecies. Metrical comparisons of dental size and proportions between extant M. s. sylvanus and fossil Macaca sylvanus florentina from the type locality and other Italian sites are undertaken, in order to classify…

Early PleistocenebiologyFossilsSkullMacaca sylvanusPostcraniaZoologyPlio-PleistoceneSubspeciesbiology.organism_classificationPaleontologyTaxonGeographystomatognathic systemEutheriaSpainAnthropologyAnimalsMacacaType localityToothEcology Evolution Behavior and SystematicsJournal of Human Evolution
researchProduct

Beta Rebound as an Index of Temporal Integration of Somatosensory and Motor Signals

2020

Modulation of cortical beta rhythm (15-30 Hz) is present during preparation for and execution of voluntary movements as well as during somatosensory stimulation. A rebound in beta synchronization is observed after the end of voluntary movements as well as after somatosensory stimulation and is believed to describe the return to baseline of sensorimotor networks. However, the contribution of efferent and afferent signals to the beta rebound remains poorly understood. Here, we applied electrical median nerve stimulation (MNS) to the right side followed by transcranial magnetic stimulation (TMS) on the left primary motor cortex after either 15 or 25 ms. Because the afferent volley reaches the …

Efferentmedicine.medical_treatmentCognitive NeuroscienceNeuroscience (miscellaneous)Socio-culturaleStimulationSomatosensory systemLateralization of brain functionlcsh:RC321-57103 medical and health sciencesCellular and Molecular Neuroscience0302 clinical medicineDevelopmental NeurosciencemedicineBeta RhythmBeta (finance)transcranial magnetic stimulation (TMS)median nerve stimulation (MNS)lcsh:Neurosciences. Biological psychiatry. Neuropsychiatry030304 developmental biologybeta rebound median nerve stimulation (MNS) motor area somatosensory area temporal integration transcranial magnetic stimulation (TMS)Original Research0303 health sciencestemporal integrationsomatosensory areamotor areabusiness.industrybeta reboundTranscranial magnetic stimulationmedicine.anatomical_structurebusinessNeuroscience030217 neurology & neurosurgeryMotor cortexNeuroscienceFrontiers in Systems Neuroscience
researchProduct

Intracranial measurement of current densities induced by transcranial magnetic stimulation in the human brain

2003

Transcranial magnetic stimulation (TMS) is a non-invasive technique that uses the principle of electromagnetic induction to generate currents in the brain via pulsed magnetic fields. The magnitude of such induced currents is unknown. In this study we measured the TMS induced current densities in a patient with implanted depth electrodes for epilepsy monitoring. A maximum current density of 12 microA/cm2 was recorded at a depth of 1 cm from scalp surface with the optimum stimulation orientation used in the experiment and an intensity of 7% of the maximal stimulator output. During TMS we recorded relative current variations under different stimulating coil orientations and at different points…

Electromagnetic fieldAdultMaterials sciencemedicine.medical_treatmentModels NeurologicalNuclear magnetic resonanceElectromagnetic FieldsEpilepsy Complex PartialmedicineHumansGeneral NeuroscienceSkullBrainTranscranial Magnetic StimulationElectric StimulationIntensity (physics)Magnetic fieldElectromagnetic inductionElectrodes ImplantedTranscranial magnetic stimulationElectromagnetic coiltranscranial magnetic stimulatione depth electrodes epilepsyBrain InjuriesFemaleCurrent (fluid)ArtifactsCurrent densityNeuroscience
researchProduct